Allysta - Crunchbase Company Profile & Funding

Q: Where is Allysta's headquarters?

Allysta is located in Bellevue, Washington, United States.

Q: Who invested in Allysta?

Allysta is funded by Morningside.

Q: When was the last funding round for Allysta?

Allysta closed its last funding round on obfuscated from a Series A round.

Overview

Allysta

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Allysta

CB Rank

116541

Allysta is a biopharmaceutical company that develops therapeutic peptides for eye diseases.

Founded

obfuscation

Private

Series A

Bellevue, Washington, United States

11-50

www.allysta.com

Biotechnology

Health Care

Medical

Therapeutics

Funding Rounds

Series A

OBF

obfuscation

Details

Legal Name

Allysta Pharmaceuticals, Inc.

Operating Status

Active

Company Type

For Profit

About the Company

Allysta develops medicines for fibrosing diseases and ocular surface inflammations. They offer anti-inflammatory, anti-fibrotic, cell-regenerative, and beneficial metabolic properties that provide opportunities for development in multiple diseases.

Contact Email

info@allysta.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

ALY688ER

An extended release formulation of ALY688 designed for prolonged delivery throughout the body, activating adiponectin signaling pathways.

ALY688 Ophthalmic Solution

A topical formulation of ALY688 developed for treating eye diseases by activating adiponectin pathways to reduce inflammation and fibrosis.

Research & Development

Allysta is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Allysta	1	obfuscated obfuscation	Morningside	Series A
obfuscated obfuscation	Series A - Allysta	1	obfuscated obfuscation	Morningside	Series A
obfuscated obfuscation	Series A - Allysta	1	obfuscated obfuscation	Morningside	Series A
obfuscated obfuscation	Series A - Allysta	1	obfuscated obfuscation	Morningside	Series A
obfuscated obfuscation	Series A - Allysta	1	obfuscated obfuscation	Morningside	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Allysta	1	obfuscated obfuscation	Morningside	Series A
obfuscated obfuscation	Series A - Allysta	1	obfuscated obfuscation	Morningside	Series A
obfuscated obfuscation	Series A - Allysta	1	obfuscated obfuscation	Morningside	Series A
obfuscated obfuscation	Series A - Allysta	1	obfuscated obfuscation	Morningside	Series A
obfuscated obfuscation	Series A - Allysta	1	obfuscated obfuscation	Morningside	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Morningside	Yes	Series A - Allysta	—
Morningside	Yes	Series A - Allysta	—
Morningside	Yes	Series A - Allysta	—
Morningside	Yes	Series A - Allysta	—
Morningside	Yes	Series A - Allysta	—